<?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName JATS-journalpublishing1.dtd?>
<?SourceDTD.Version 1.1?>
<?ConverterInfo.XSLTName jats2jats3.xsl?>
<?ConverterInfo.Version 1?>
<?properties open_access?>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">Bioinformatics</journal-id>
    <journal-id journal-id-type="iso-abbrev">Bioinformatics</journal-id>
    <journal-id journal-id-type="publisher-id">bioinformatics</journal-id>
    <journal-title-group>
      <journal-title>Bioinformatics</journal-title>
    </journal-title-group>
    <issn pub-type="ppub">1367-4803</issn>
    <issn pub-type="epub">1367-4811</issn>
    <publisher>
      <publisher-name>Oxford University Press</publisher-name>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">8248894</article-id>
    <article-id pub-id-type="pmid">31750874</article-id>
    <article-id pub-id-type="doi">10.1093/bioinformatics/btz875</article-id>
    <article-id pub-id-type="publisher-id">btz875</article-id>
    <article-categories>
      <subj-group subj-group-type="heading">
        <subject>Original Papers</subject>
        <subj-group subj-group-type="heading">
          <subject>Genetics and Population Analysis</subject>
        </subj-group>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>Easy-HLA: a validated web application suite to reveal the full details of HLA
typing</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author">
        <name>
          <surname>Geffard</surname>
          <given-names>Estelle</given-names>
        </name>
        <xref rid="btz875-aff1" ref-type="aff">1</xref>
        <xref rid="btz875-cor1" ref-type="corresp"/>
        <!--easyhla@gmail.com-->
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Limou</surname>
          <given-names>Sophie</given-names>
        </name>
        <xref rid="btz875-aff1" ref-type="aff">1</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Walencik</surname>
          <given-names>Alexandre</given-names>
        </name>
        <xref rid="btz875-aff1" ref-type="aff">1</xref>
        <xref rid="btz875-aff2" ref-type="aff">2</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Daya</surname>
          <given-names>Michelle</given-names>
        </name>
        <xref rid="btz875-aff3" ref-type="aff">3</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Watson</surname>
          <given-names>Harold</given-names>
        </name>
        <xref rid="btz875-aff4" ref-type="aff">4</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Torgerson</surname>
          <given-names>Dara</given-names>
        </name>
        <xref rid="btz875-aff5" ref-type="aff">5</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Barnes</surname>
          <given-names>Kathleen C</given-names>
        </name>
      </contrib>
      <contrib contrib-type="author">
        <collab>on behalf of CAAPA</collab>
        <xref rid="btz875-aff3" ref-type="aff">3</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Cesbron Gautier</surname>
          <given-names>Anne</given-names>
        </name>
        <xref rid="btz875-aff2" ref-type="aff">2</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Gourraud</surname>
          <given-names>Pierre-Antoine</given-names>
        </name>
        <xref rid="btz875-aff1" ref-type="aff">1</xref>
        <xref rid="btz875-cor1" ref-type="corresp"/>
        <!--pierre-antoine.gourraud@univ-nantes.fr-->
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Vince</surname>
          <given-names>Nicolas</given-names>
        </name>
        <xref rid="btz875-aff1" ref-type="aff">1</xref>
      </contrib>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name>
          <surname>Valencia</surname>
          <given-names>Alfonso</given-names>
        </name>
        <role>Associate Editor</role>
      </contrib>
    </contrib-group>
    <aff id="btz875-aff1"><label>1</label><institution>Nantes Université, Centrale Nantes, CHU Nantes, Inserm, Centre de Recherche en
Transplantation et Immunologie</institution>, UMR 1064, ITUN, Nantes F-44000, <country country="FR">France</country></aff>
    <aff id="btz875-aff2"><label>2</label><institution>Laboratoire d’Histocompatibilité et d’Immunogénétique, EFS Centre—Pays de la
Loire</institution>, Nantes F-44000, <country country="FR">France</country></aff>
    <aff id="btz875-aff3"><label>3</label><institution>Department of Medicine, University of Colorado Denver</institution>, Aurora, CO
80045, <country country="US">USA</country></aff>
    <aff id="btz875-aff4"><label>4</label><institution>Faculty of Medical Sciences Cave Hill Campus, The University of the West
Indies</institution>, Bridgetown BB11000, Barbados</aff>
    <aff id="btz875-aff5"><label>5</label><institution>McGill University and Genome Quebec Innovation Centre</institution>, Montreal,
QC H3A 0G1, <country country="CA">Canada</country></aff>
    <author-notes>
      <corresp id="btz875-cor1">To whom correspondence should be addressed. E-mail:
<email>easyhla@gmail.com</email> or
<email>pierre-antoine.gourraud@univ-nantes.fr</email></corresp>
    </author-notes>
    <pub-date pub-type="ppub">
      <day>01</day>
      <month>4</month>
      <year>2020</year>
    </pub-date>
    <pub-date pub-type="epub" iso-8601-date="2019-11-21">
      <day>21</day>
      <month>11</month>
      <year>2019</year>
    </pub-date>
    <pub-date pub-type="pmc-release">
      <day>21</day>
      <month>11</month>
      <year>2019</year>
    </pub-date>
    <volume>36</volume>
    <issue>7</issue>
    <fpage>2157</fpage>
    <lpage>2164</lpage>
    <history>
      <date date-type="received">
        <day>06</day>
        <month>12</month>
        <year>2018</year>
      </date>
      <date date-type="rev-recd">
        <day>19</day>
        <month>9</month>
        <year>2019</year>
      </date>
      <date date-type="accepted">
        <day>20</day>
        <month>11</month>
        <year>2019</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>© The Author(s) 2019. Published by Oxford University
Press.</copyright-statement>
      <copyright-year>2019</copyright-year>
      <license>
        <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbynclicense">https://creativecommons.org/licenses/by-nc/4.0/</ali:license_ref>
        <license-p>This is an Open Access article distributed under the terms of the Creative
Commons Attribution Non-Commercial License (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc/4.0/">http://creativecommons.org/licenses/by-nc/4.0/</ext-link>), which permits
non-commercial re-use, distribution, and reproduction in any medium, provided the
original work is properly cited. For commercial re-use, please contact
journals.permissions@oup.com</license-p>
      </license>
    </permissions>
    <self-uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="btz875.pdf"/>
    <abstract>
      <title>Abstract</title>
      <sec id="s1">
        <title>Motivation</title>
        <p>The HLA system plays a pivotal role in both clinical applications and immunology
research. Typing HLA genes in patient and donor is indeed required in hematopoietic stem
cell and solid-organ transplantation, and the histocompatibility complex region exhibits
countless genetic associations with immune-related pathologies. Since the discovery of
HLA antigens, the HLA system nomenclature and typing methods have constantly evolved,
which leads to difficulties in using data generated with older methodologies.</p>
      </sec>
      <sec id="s2">
        <title>Results</title>
        <p>Here, we present Easy-HLA, a web-based software suite designed to facilitate analysis
and gain knowledge from HLA typing, regardless of nomenclature or typing method.
Easy-HLA implements a computational and statistical method of HLA haplotypes inference
based on published reference populations containing over 600 000 haplotypes to upgrade
missing or partial HLA information: ‘HLA-Upgrade’ tool infers high-resolution HLA typing
and ‘HLA-2-Haplo’ imputes haplotype pairs and provides additional functional annotations
(e.g. amino acids and KIR ligands). We validated both tools using two independent
cohorts (total <italic toggle="yes">n</italic> = 2500). For HLA-Upgrade, we reached a prediction
accuracy of 92% from low- to high-resolution of European genotypes. We observed a 96%
call rate and 76% accuracy with HLA-2-Haplo European haplotype pairs prediction. In
conclusion, Easy-HLA tools facilitate large-scale immunogenetic analysis and promotes
the multi-faceted HLA expertise beyond allelic associations by providing new functional
immunogenomics parameters.</p>
      </sec>
      <sec id="s3">
        <title>Availability and implementation</title>
        <p>Easy-HLA is a web application freely available (free account) at: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://hla.univ-nantes.fr" ext-link-type="uri">https://hla.univ-nantes.fr</ext-link>.</p>
      </sec>
      <sec id="s4">
        <title>Supplementary information</title>
        <p><xref rid="sup1" ref-type="supplementary-material">Supplementary data</xref> are
available at <italic toggle="yes">Bioinformatics</italic> online.</p>
      </sec>
    </abstract>
    <funding-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>Labex IGO</institution>
          </institution-wrap>
        </funding-source>
        <award-id>ANR-11-LABX-0016-01</award-id>
      </award-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>IHU-CESTI</institution>
          </institution-wrap>
        </funding-source>
      </award-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>European Union’s Horizon 2020</institution>
          </institution-wrap>
        </funding-source>
      </award-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>Skłodowska-Curie</institution>
          </institution-wrap>
        </funding-source>
        <award-id>846520</award-id>
      </award-group>
    </funding-group>
    <counts>
      <page-count count="8"/>
    </counts>
  </article-meta>
</front>
<body>
  <sec>
    <title>1 Introduction</title>
    <p>HLA genes from the major histocompatibility complex (MHC) encode a specific group of cell
surface molecules mediating recognition of non-self-antigens by the immune system. HLA plays
key roles in transplantation management and success. HLA matching between a patient and
potential donors is essential in hematopoietic stem cell transplantation (HSCT) (<xref rid="btz875-B4" ref-type="bibr">Copelan, 2006</xref>; <xref rid="btz875-B18" ref-type="bibr">Loiseau <italic toggle="yes">et al.</italic>, 2007</xref>) and solid-organ
transplantations (<xref rid="btz875-B12" ref-type="bibr">Held <italic toggle="yes">et al.</italic>,
1994</xref>). Donor-recipient compatibility is defined by the number of alleles shared
across HLA-A, -B, -C, -DRB1 and -DQB1 genes. The chance of graft success is optimal when
donor and recipient are fully compatible and have the lowest number of HLA alleles
mismatches (<xref rid="btz875-B17" ref-type="bibr">Lee <italic toggle="yes">et al.</italic>, 2007</xref>;
<xref rid="btz875-B29" ref-type="bibr">Zachary and Leffell, 2016</xref>). The level of
typing resolution is positively correlated with the probability of allele matching during
donor search. Additionally, time restrictions in solid-organ transplantation from deceased
donors often make HLA allele high-resolution typing impossible, and only intermediate
resolution or even low-resolution genotyping may be available at the time of organ
allocation. Beyond these major clinical impacts, HLA has been frequently associated with
numerous immune-related pathologies (<xref rid="btz875-B19" ref-type="bibr">MacArthur
<italic toggle="yes">et al.</italic>, 2017</xref>; <xref rid="btz875-B27" ref-type="bibr">Tian
et al., 2017</xref>; <xref rid="btz875-B28" ref-type="bibr">Vince <italic toggle="yes">et al.</italic>,
2014</xref>).</p>
    <p>MHC genomic region on chromosome 6 (6p21.3) is the most complex and polymorphic locus of
the human genome (<xref rid="btz875-B14" ref-type="bibr">Howell <italic toggle="yes">et al.</italic>,
2010</xref>). The MHC counts &gt;220 genes (<xref rid="btz875-B13" ref-type="bibr">Horton
<italic toggle="yes">et al.</italic>, 2004</xref>), including 21 polymorphic HLA genes from the
classical HLA class I (e.g. HLA-A, HLA-B and HLA-C) and HLA class II (e.g. HLA-DRB1 and
HLA-DQB1). The HLA system comprises &gt;22 000 described alleles (<xref rid="btz875-B23" ref-type="bibr">Robinson <italic toggle="yes">et al.</italic>, 2015</xref>) (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.ebi.ac.uk/ipd/imgt/hla/stats.html" ext-link-type="uri">https://www.ebi.ac.uk/ipd/imgt/hla/stats.html</ext-link>). HLA alleles correspond to a
specific sequence of HLA genes and can be considered as single nucleotide variants
(including tetra-allelic ones as well as insertions and deletions) haplotypes. HLA
haplotypes can be constructed from these HLA alleles; here, we consider the five main genes
HLA-A∼B∼C∼DRB1∼DQB1 for haplotyping, and named the 5-gene haplotypes as the following
example: A*34:02∼B*14:01∼C*08:02∼DRB1*04:05∼DQB1*03:02. The complexity of this region is not
only due to its diversity but also to its linkage disequilibrium (LD). LD is defined as the
non-random association of neighboring polymorphisms, i.e. the difference between the
observed frequency of allele combinations (haplotypes) and the expected frequency under
random transmission. LD and haplotype frequencies are shaped by selective pressure, genetic
drift, non-random mating, recombination events and shared genetic effect between alleles
(<xref rid="btz875-B1" ref-type="bibr">Ahmad <italic toggle="yes">et al.</italic>, 2003</xref>; <xref rid="btz875-B8" ref-type="bibr">Goodin <italic toggle="yes">et al.</italic>, 2018</xref>).</p>
    <p>HLA typing techniques have considerably evolved over the years with a wide array of methods
providing increasing levels of resolution (<xref rid="btz875-B6" ref-type="bibr">Erlich,
2012</xref>, <xref rid="btz875-T1" ref-type="table">Table 1</xref>). Historically,
phenotyping was performed by detecting HLA proteins on cell surface with specific
antibodies. These serology-based methods have progressively been replaced with DNA-based
typing. Today, full-length HLA genes sequenced through Next-Generation Sequencing (NGS)
provides the highest standard and resolution. In parallel with HLA typing methods,
nomenclature has greatly evolved (<xref rid="btz875-T1" ref-type="table">Table 1</xref>),
which nowadays significantly hampers retrospective analyses and HSCT compatible donor search
from archived HLA datasets recorded in low/mid-resolutions with possibly some missing genes
(e.g. HLA-C or HLA-DQB1) (<xref rid="btz875-B15" ref-type="bibr">Hurley <italic toggle="yes">et
al.</italic>, 2004</xref>). This major pitfall for clinics and biomedical research
highlights the crucial need for high-resolution allele imputation from low or intermediate
resolution in order to reduce allele ambiguity by simultaneously increasing genotype
resolution and imputing unknown genes (<xref rid="btz875-B20" ref-type="bibr">Madbouly
<italic toggle="yes">et al.</italic>, 2014</xref>). </p>
    <table-wrap position="float" id="btz875-T1">
      <label>Table 1.</label>
      <caption>
        <p>Common nomenclature reporting HLA types</p>
      </caption>
      <table frame="hsides" rules="groups">
        <colgroup span="1">
          <col valign="top" align="left" span="1"/>
          <col valign="top" align="left" span="1"/>
          <col valign="top" align="left" span="1"/>
          <col valign="top" align="left" span="1"/>
        </colgroup>
        <thead>
          <tr>
            <th rowspan="1" colspan="1">Name</th>
            <th align="left" rowspan="1" colspan="1">Typing</th>
            <th align="left" rowspan="1" colspan="1">Resolution</th>
            <th align="left" rowspan="1" colspan="1">Nomenclature</th>
          </tr>
        </thead>
        <tbody>
          <tr>
            <td rowspan="1" colspan="1">Broad serology</td>
            <td rowspan="1" colspan="1">Phenotyping (lymphocytotoxicity)</td>
            <td rowspan="1" colspan="1">Low</td>
            <td rowspan="1" colspan="1">B14</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">Split serology</td>
            <td rowspan="1" colspan="1">Phenotyping (lymphocytotoxicity)</td>
            <td rowspan="1" colspan="1">Low</td>
            <td rowspan="1" colspan="1">B64 B65</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">First-field</td>
            <td rowspan="1" colspan="1">Genotyping (PCR SSP)</td>
            <td rowspan="1" colspan="1">Low</td>
            <td rowspan="1" colspan="1">B*14</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">NMDP code</td>
            <td rowspan="1" colspan="1">Genotyping (PCR SSO)</td>
            <td rowspan="1" colspan="1">Intermediate</td>
            <td rowspan="1" colspan="1">14:HUJ</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">Second-field</td>
            <td rowspan="1" colspan="1">Genotyping (Sanger sequencing and/or NGS)</td>
            <td rowspan="1" colspan="1">High</td>
            <td rowspan="1" colspan="1">B*14:01 B*14:02</td>
          </tr>
        </tbody>
      </table>
      <table-wrap-foot>
        <fn id="tblfn1">
          <p><italic toggle="yes">Note</italic>: <italic toggle="yes">HLA</italic> alleles nomenclature established by the
World Health Organization Nomenclature Committee (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://hla.alleles.org/nomenclature/committee.html" ext-link-type="uri">http://hla.alleles.org/nomenclature/committee.html</ext-link>). Nomenclature is
regularly updated. Here, we consider <italic toggle="yes">HLA</italic>-B*14:01:01 as an example.
‘NMDP codes’ allele codes narrow the list of alleles that must be considered at a
given locus by eliminating some possibilities (e.g. B*14:HUJ means that the typing is
either B*14:01 or B*14:02). ‘NMDP codes’ are implemented and updated by the NMDP
(<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://bioinformatics.bethematchclinical.org/hla-resources/allele-codes/allele-code-lists/allele-code-list-in-alphabetical-order/" ext-link-type="uri">https://bioinformatics.bethematchclinical.org/hla-resources/allele-codes/allele-code-lists/allele-code-list-in-alphabetical-order/)</ext-link>.
PCR SSO: sequence specific oligonucleotide. PCR SSP: sequence specific primers (<xref rid="btz875-B14" ref-type="bibr">Howell <italic toggle="yes">et al.</italic>, 2010</xref>).</p>
        </fn>
      </table-wrap-foot>
    </table-wrap>
    <p>Finally, many current typing technologies are not designed to deliver full-length HLA
haplotypes. Knowledge of haplotype pairs can be particularly useful to determine if
unrelated individuals have a chance to be haplo-identical in an HSCT clinical setting; and
in research, haplotypes are necessary for functional annotations. Familial explorations can
be performed to determine haplotypes from parental genotypes; however, this technique is
expensive and challenging to implement as it requires access to relatives’ DNA. Beyond this
family-based approach, computational haplotype inference based on probabilistic models from
genotypic data has been proposed (<xref rid="btz875-B24" ref-type="bibr">Salem <italic toggle="yes">et
al.</italic>, 2005</xref>). Several methods for haplotype inference exist, from
algorithms based on parsimony (<xref rid="btz875-B3" ref-type="bibr">Clark, 1990</xref>) or
on likelihood [such as the Expectation-Maximization (EM) algorithms] (<xref rid="btz875-B7" ref-type="bibr">Excoffier and Slatkin, 1995</xref>) to Bayesian algorithms (<xref rid="btz875-B26" ref-type="bibr">Stephens and Donnelly, 2003</xref>). Overall, the most
commonly used methods to compute HLA haplotypes are EM-based algorithms (<xref rid="btz875-B5" ref-type="bibr">Eberhard <italic toggle="yes">et al.</italic>, 2013</xref>), which can
accommodate several loci with an arbitrary number of alleles for a large number of
individuals with ambiguous haplotypes (<xref rid="btz875-B5" ref-type="bibr">Eberhard
<italic toggle="yes">et al.</italic>, 2013</xref>; <xref rid="btz875-B24" ref-type="bibr">Salem
<italic toggle="yes">et al.</italic>, 2005</xref>). However, they show limited performance with small
sample size and do not support haplotype determination from a unique individual. Moreover,
results are dependent on inherent dataset characteristics: individuals genetic
heterogeneity, number of loci and genotype resolution (<xref rid="btz875-B5" ref-type="bibr">Eberhard <italic toggle="yes">et al.</italic>, 2013</xref>). These methods are not always
straightforward or need powerful computation (<xref rid="btz875-B24" ref-type="bibr">Salem
<italic toggle="yes">et al.</italic>, 2005</xref>). Previously, a maximum likelihood-based HLA
haplotype imputation technique was validated on several datasets for unrelated HSCT donor
search (<xref rid="btz875-B9" ref-type="bibr">Gourraud <italic toggle="yes">et al.</italic>,
2005</xref>). This method computes the most likely haplotype pair from HLA genotypes based
on HLA genotype frequencies throughout donor transplant registries. Most of the reference
haplotype frequencies come from the large reference population of the National Marrow Donor
Program (NMDP). NMDP designates the US voluntary bone marrow donor registry. This registry
has proposed several breakthroughs in the field of bone marrow transplantation by making
available the large HLA haplotype database used in the current study, and also, by creating
a specific nomenclature: ‘NMDP codes’. These codes allow to describe HLA typing with some
allele ambiguity represented by two to five letter codes (<xref rid="btz875-T1" ref-type="table">Table 1</xref>).</p>
    <p>Following this strategy, we developed Easy-HLA, a user-friendly web application designed to
deliver a complete suite of HLA annotations (freely available through a secure connection at
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://hla.univ-nantes.fr" ext-link-type="uri">https://hla.univ-nantes.fr</ext-link>). From HLA
genotypes and regardless of resolution level, Easy-HLA can statistically resolve HLA
genotype ambiguity, and increase HLA data resolution and functional annotations. Easy-HLA
facilitates the use of HLA data collected from both classical and historic laboratory
procedures. In this article, we present our application and its validation using independent
cohorts delivering optimized information for immunogenetic investigations.</p>
  </sec>
  <sec>
    <title>2 Implementation</title>
    <p>Easy-HLA is a web-based application suite designed to predict haplotypes from HLA
genotypes. The input HLA genotypes can be entered with low/mid-resolution and/or can contain
ambiguities, in a single request (one individual genotype) or batch mode (several
individuals genotypes). Regarding security and data storage, the loaded data files are
deleted immediately after analysis completion, and the output data files are safely
conserved on our server for 1 week.</p>
    <p>We implemented our tools with web scripting languages using PHP (Hypertext Preprocessor)
combined with the pgSQL procedural language. The pgSQL language is used to interrogate the
haplotype database and find haplotype pairs corresponding to the input genotype. PHP
functions were designed to query multiple databases (serological identity, NMDP nomenclature
equivalence) to translate the HLA nomenclature complexity. We used estimates from maximum
likelihood-based statistical method to infer HLA haplotypes and subsequently predict
unavailable HLA information.</p>
    <sec>
      <title>2.1 Database</title>
      <p>Easy-HLA main algorithm is based on HLA haplotype frequencies from a large reference
population, these frequencies were obtained with a maximum likelihood-based HLA haplotype
imputation technique previously validated (<xref rid="btz875-B9" ref-type="bibr">Gourraud
<italic toggle="yes">et al.</italic>, 2005</xref>). We stored our data in a PostgreSQL database.
The core reference haplotype frequencies come from the NMDP published in 2013 for uses in
clinical transplant and immunological research (<xref rid="btz875-B11" ref-type="bibr">Gragert <italic toggle="yes">et al.</italic>, 2013</xref>). From the HLA genotypes of 6.59 million
US subjects, the NMDP estimated high-resolution HLA haplotype frequencies in five
ancestral populations using an EM algorithm (<xref rid="btz875-B25" ref-type="bibr">Schaid
<italic toggle="yes">et al.</italic>, 2002</xref>). The large sample size allows an accurate
estimation of rare alleles and haplotype frequencies. The NMDP haplotype database thereby
reports frequencies of over 600 000 haplotypes divided into five ancestral populations
(African-Americans: 198 216; Asian and Pacific Islanders: 158 307; Europeans: 304 697;
Hispanics: 220 020 and Native-Americans: 36 417). We completed this large dataset with
RFGM (Registre France Greffe de Moelle), a French population database containing
&gt;16 000 haplotypes (<xref rid="btz875-B10" ref-type="bibr">Gourraud <italic toggle="yes">et
al.</italic>, 2015</xref>; <xref rid="btz875-B22" ref-type="bibr">Pappas <italic toggle="yes">et
al.</italic>, 2015</xref>). The user has the possibility to choose the best matching
reference population with his/her input individual(s) ancestry among these six reference
datasets.</p>
    </sec>
    <sec>
      <title>2.2 Algorithm</title>
      <p>From each HLA genotype, our algorithm enumerates each possible haplotype pair and
computes the corresponding likelihood. Considering a diploid genotype (<italic toggle="yes">G</italic>)
for three HLA genes (<italic toggle="yes">A</italic>, <italic toggle="yes">B</italic> and <italic toggle="yes">C</italic>) and
two alleles per gene (upper and lower cases), we obtain four distinct theoretical
haplotype pairs [or diplotypes, <italic toggle="yes">d</italic>1–4, <xref rid="E1" ref-type="disp-formula">Equation (1)</xref>]. We can generalize the computation of <italic toggle="yes">N</italic>
theoretical diplotypes from a diploid genotype (<italic toggle="yes">G</italic>) for <italic toggle="yes">x</italic>
genes (with heterozygous alleles) with the equation
<italic toggle="yes">N</italic> = 2<sup><italic toggle="yes">x</italic></sup><sup>−1</sup>.</p>
      <p>Enumeration of diplotypes <disp-formula id="E1"><label>(1)</label><inline-graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="btz875ilf1.jpg"/></disp-formula></p>
      <p>Our algorithm is founded on a reference database of HLA haplotype frequencies
(<italic toggle="yes">f</italic>) in different populations: haplotypes not reported in the reference
dataset are removed from the haplotype list
[<italic toggle="yes">a</italic>∼<italic toggle="yes">B</italic>∼<italic toggle="yes">C</italic> strikethrough in
<italic toggle="yes">d</italic>3 in <xref rid="E1" ref-type="disp-formula">Equation (1)]</xref>,
resulting in <italic toggle="yes">n</italic> previously observed pairs of haplotypes (here,
<italic toggle="yes">n</italic> = 3) and therefore reducing the space of haplotypes to explore.</p>
      <p>We calculated genotypic frequencies from haplotype frequencies by following Hardy
Weinberg's genetic distribution law. When a diplotype is homozygous, the likelihood
(<italic toggle="yes">L</italic>) is the squared value of the haplotype frequency
(<italic toggle="yes">f</italic>2). When the diplotype is heterozygous the likelihood
(<italic toggle="yes">L</italic>) is:</p>
      <p>Likelihood of an enumerated heterozygous diplotype <disp-formula id="E2"><label>(2)</label><mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M1" display="block" overflow="scroll"><mml:mi>L</mml:mi><mml:mfenced open="(" close=")" separators="|"><mml:mrow><mml:mi>d</mml:mi><mml:mn>1</mml:mn><mml:mfenced open="(" close=")" separators="|"><mml:mrow><mml:mi>A</mml:mi><mml:mo> </mml:mo><mml:mo>∼</mml:mo><mml:mo> </mml:mo><mml:mi>B</mml:mi><mml:mo> </mml:mo><mml:mo>∼</mml:mo><mml:mo> </mml:mo><mml:mi>C</mml:mi><mml:mo>,</mml:mo><mml:mo> </mml:mo><mml:mi>a</mml:mi><mml:mo> </mml:mo><mml:mo>∼</mml:mo><mml:mo> </mml:mo><mml:mi>b</mml:mi><mml:mo> </mml:mo><mml:mo>∼</mml:mo><mml:mo> </mml:mo><mml:mi>c</mml:mi></mml:mrow></mml:mfenced></mml:mrow></mml:mfenced><mml:mo>=</mml:mo><mml:mn>2</mml:mn><mml:mo>*</mml:mo><mml:mi>f</mml:mi><mml:mo>(</mml:mo><mml:mi>A</mml:mi><mml:mo> </mml:mo><mml:mo>∼</mml:mo><mml:mo> </mml:mo><mml:mi>B</mml:mi><mml:mo> </mml:mo><mml:mo>∼</mml:mo><mml:mo> </mml:mo><mml:mi>C</mml:mi><mml:mo>)</mml:mo><mml:mo>*</mml:mo><mml:mi>f</mml:mi><mml:mo>(</mml:mo><mml:mi>a</mml:mi><mml:mo> </mml:mo><mml:mo>∼</mml:mo><mml:mo> </mml:mo><mml:mi>b</mml:mi><mml:mo> </mml:mo><mml:mo>∼</mml:mo><mml:mo> </mml:mo><mml:mi>c</mml:mi><mml:mo>)</mml:mo></mml:math></disp-formula>where
<italic toggle="yes">f</italic>(<italic toggle="yes">A</italic> ∼ <italic toggle="yes">B</italic> ∼ <italic toggle="yes">C</italic>) and
<italic toggle="yes">f</italic>(<italic toggle="yes">a</italic> ∼ <italic toggle="yes">b</italic> ∼ <italic toggle="yes">c</italic>)
corresponds to the respective frequencies of each haplotype. The number of homozygous
diplotypes is low (<xref rid="btz875-B11" ref-type="bibr">Gragert <italic toggle="yes">et al.</italic>,
2013</xref>); therefore, we consider only the likelihood for heterozygous
diplotypes.</p>
      <p>When HLA genotypes are specified with allelic ambiguities (low-resolution) and/or untyped
loci (incomplete genotype), multiple alternative diplotypes can be inferred. For allele
ambiguity, the Easy-HLA imputation algorithm produces all possible HLA genotypes
associated with the ambiguous input. Correspondingly, when a locus is missing [in our
example, the HLA-B gene was not typed and is recorded as XX—<xref rid="E3" ref-type="disp-formula">Equation (3)]</xref>, Easy-HLA generates all possible alleles for this missing
gene (<italic toggle="yes">B</italic>, <italic toggle="yes">b</italic> and <italic toggle="yes">β</italic>). <xref rid="E3" ref-type="disp-formula">Equation (3)</xref> displays only haplotypes pairs
reported in our reference database with a frequency above the user-defined threshold.
Indeed, we do not show every possible theoretical haplotype pairs as many are not observed
in our population datasets, and would therefore have a null estimated frequency.</p>
      <p>Enumeration of diplotypes from an incomplete genotype with a missing locus using all
compatible haplotypes present in our database <disp-formula id="E3"><label>(3)</label><mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M2" display="block" overflow="scroll"><mml:mi>G</mml:mi><mml:mfenced open="(" close=")" separators="|"><mml:mrow><mml:mi>A</mml:mi><mml:mo> </mml:mo><mml:mi>a</mml:mi><mml:mo>∼</mml:mo><mml:mi mathvariant="italic">XX</mml:mi><mml:mo> </mml:mo><mml:mo>∼</mml:mo><mml:mo> </mml:mo><mml:mi mathvariant="italic">Cc</mml:mi></mml:mrow></mml:mfenced><mml:mfenced open="{" close="" separators="|"><mml:mrow><mml:mtable><mml:mtr><mml:mtd><mml:mrow><mml:maligngroup/><mml:mi>d</mml:mi><mml:mn>1</mml:mn><mml:mo> </mml:mo><mml:mfenced open="(" close=")" separators="|"><mml:mrow><mml:mi>A</mml:mi><mml:mo> </mml:mo><mml:mo>∼</mml:mo><mml:mo> </mml:mo><mml:mi>B</mml:mi><mml:mo> </mml:mo><mml:mo>∼</mml:mo><mml:mo> </mml:mo><mml:mi>C</mml:mi><mml:mo>,</mml:mo><mml:mo> </mml:mo><mml:mi>a</mml:mi><mml:mo> </mml:mo><mml:mo>∼</mml:mo><mml:mo> </mml:mo><mml:mi>b</mml:mi><mml:mo> </mml:mo><mml:mo>∼</mml:mo><mml:mo> </mml:mo><mml:mi>c</mml:mi></mml:mrow></mml:mfenced></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow><mml:maligngroup/><mml:mi>d</mml:mi><mml:mn>2</mml:mn><mml:mo> </mml:mo><mml:mfenced open="(" close=")" separators="|"><mml:mrow><mml:mi>A</mml:mi><mml:mo> </mml:mo><mml:mo>∼</mml:mo><mml:mo> </mml:mo><mml:mi>b</mml:mi><mml:mo> </mml:mo><mml:mo>∼</mml:mo><mml:mo> </mml:mo><mml:mi>C</mml:mi><mml:mo>,</mml:mo><mml:mo> </mml:mo><mml:mi>a</mml:mi><mml:mo> </mml:mo><mml:mo>∼</mml:mo><mml:mo> </mml:mo><mml:mi>B</mml:mi><mml:mo> </mml:mo><mml:mo>∼</mml:mo><mml:mo> </mml:mo><mml:mi>c</mml:mi></mml:mrow></mml:mfenced></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow><mml:maligngroup/><mml:mi>d</mml:mi><mml:mn>3</mml:mn><mml:mo> </mml:mo><mml:mfenced open="(" close=")" separators="|"><mml:mrow><mml:mi>A</mml:mi><mml:mo> </mml:mo><mml:mo>∼</mml:mo><mml:mo> </mml:mo><mml:mo>β</mml:mo><mml:mo> </mml:mo><mml:mo>∼</mml:mo><mml:mo> </mml:mo><mml:mi>c</mml:mi><mml:mo>,</mml:mo><mml:mo> </mml:mo><mml:mi>a</mml:mi><mml:mo> </mml:mo><mml:mo>∼</mml:mo><mml:mo> </mml:mo><mml:mi>b</mml:mi><mml:mo> </mml:mo><mml:mo>∼</mml:mo><mml:mo> </mml:mo><mml:mi>C</mml:mi></mml:mrow></mml:mfenced></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow><mml:maligngroup/><mml:mi>d</mml:mi><mml:mn>4</mml:mn><mml:mo> </mml:mo><mml:mfenced open="(" close=")" separators="|"><mml:mrow><mml:mi>A</mml:mi><mml:mo> </mml:mo><mml:mo>∼</mml:mo><mml:mo> </mml:mo><mml:mo>β</mml:mo><mml:mo> </mml:mo><mml:mo>∼</mml:mo><mml:mo> </mml:mo><mml:mi>c</mml:mi><mml:mo>,</mml:mo><mml:mo> </mml:mo><mml:mi>a</mml:mi><mml:mo> </mml:mo><mml:mo>∼</mml:mo><mml:mo> </mml:mo><mml:mo>β</mml:mo><mml:mo> </mml:mo><mml:mo>∼</mml:mo><mml:mo> </mml:mo><mml:mi>C</mml:mi></mml:mrow></mml:mfenced></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:mfenced></mml:math></disp-formula></p>
      <p>From an incomplete HLA genotype, Easy-HLA algorithm hence produces all possible
diplotypes and then computes their corresponding likelihood. For each diplotype, a
confidence measurement named post-probability (Post-<italic toggle="yes">P</italic>) is calculated as
the ratio of likelihood of a particular diplotype
(<italic toggle="yes">L</italic>(<italic toggle="yes">dt</italic>)) among the likelihood of all <italic toggle="yes">n</italic>
possible diplotypes (<italic toggle="yes">L</italic>(<italic toggle="yes">di</italic>)):</p>
      <p>Post-probability of each possible diplotype <disp-formula id="E4"><label>(4)</label><mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M3" display="block" overflow="scroll"><mml:mi mathvariant="normal">Post</mml:mi><mml:mo>-</mml:mo><mml:mi>P</mml:mi><mml:mfenced open="(" close=")" separators="|"><mml:mrow><mml:mi mathvariant="italic">dt</mml:mi></mml:mrow></mml:mfenced><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mi>L</mml:mi><mml:mfenced open="(" close=")" separators="|"><mml:mrow><mml:mi mathvariant="italic">dt</mml:mi></mml:mrow></mml:mfenced></mml:mrow><mml:mrow><mml:mrow><mml:msubsup><mml:mo stretchy="false">∑</mml:mo><mml:mrow><mml:mi>i</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mi>n</mml:mi></mml:mrow></mml:msubsup><mml:mrow><mml:mi mathvariant="normal"> </mml:mi><mml:mi>L</mml:mi><mml:mfenced open="(" close=")" separators="|"><mml:mrow><mml:mi mathvariant="italic">di</mml:mi></mml:mrow></mml:mfenced></mml:mrow></mml:mrow></mml:mrow></mml:mfrac></mml:math></disp-formula>where
<italic toggle="yes">i</italic> is an index for enumerating the different diplotypes and
<italic toggle="yes">n</italic> is the number of possible diplotypes. The post-probability of the
most likely diplotype is then:</p>
      <p>Post-probability of the most likely diplotype <disp-formula id="E5"><label>(5)</label><mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M4" display="block" overflow="scroll"><mml:mi mathvariant="normal">Post</mml:mi><mml:mo>-</mml:mo><mml:mi>P</mml:mi><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mrow><mml:mrow><mml:mi mathvariant="normal">max</mml:mi></mml:mrow><mml:mo>⁡</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mi>L</mml:mi><mml:mfenced open="(" close=")" separators="|"><mml:mrow><mml:mi mathvariant="italic">di</mml:mi></mml:mrow></mml:mfenced><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:mrow><mml:mrow><mml:mrow><mml:msubsup><mml:mo stretchy="false">∑</mml:mo><mml:mrow><mml:mi>i</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mi>n</mml:mi></mml:mrow></mml:msubsup><mml:mrow><mml:mi mathvariant="normal"> </mml:mi><mml:mi>L</mml:mi><mml:mfenced open="(" close=")" separators="|"><mml:mrow><mml:mi mathvariant="italic">di</mml:mi></mml:mrow></mml:mfenced></mml:mrow></mml:mrow></mml:mrow></mml:mfrac><mml:mo> </mml:mo></mml:math></disp-formula></p>
      <p>The diplotype with the highest post-probability is by definition dependent of the
haplotype frequencies in the reference dataset. When interpreting the output, one has to
be cautious when top post-probabilities are close, as the real haplotype pair might then
not always be the most likely.</p>
      <p>From the likelihood of each predicted diplotype, Easy-HLA can then infer a
high-resolution genotype for the incomplete or ambiguous input genotype. The likelihood
(<italic toggle="yes">L</italic>) of the imputed high-resolution genotype is:</p>
      <p>Likelihood of the imputed high-resolution genotype <disp-formula id="E6"><label>(6)</label><mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M5" display="block" overflow="scroll"><mml:mi>L</mml:mi><mml:mfenced open="(" close=")" separators="|"><mml:mrow><mml:mi>G</mml:mi><mml:mfenced open="(" close=")" separators="|"><mml:mrow><mml:mi>A</mml:mi><mml:mo> </mml:mo><mml:mi>a</mml:mi><mml:mo>∼</mml:mo><mml:mo> </mml:mo><mml:mi mathvariant="italic">Bb</mml:mi><mml:mo> </mml:mo><mml:mo>∼</mml:mo><mml:mo> </mml:mo><mml:mi mathvariant="italic">Cc</mml:mi></mml:mrow></mml:mfenced></mml:mrow></mml:mfenced><mml:mo>=</mml:mo><mml:mrow><mml:munderover><mml:mo stretchy="false">∑</mml:mo><mml:mrow><mml:mi>i</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mi>n</mml:mi></mml:mrow></mml:munderover><mml:mrow><mml:mi>L</mml:mi><mml:mo>(</mml:mo></mml:mrow></mml:mrow><mml:mi>d</mml:mi><mml:mi>i</mml:mi><mml:mo>)</mml:mo></mml:math></disp-formula>where
<italic toggle="yes">i</italic> is an index for enumerating the different diplotypes
<italic toggle="yes">di</italic>, <italic toggle="yes">n</italic> is the number of possible diplotypes and
<italic toggle="yes">L</italic> is the likelihood of a diplotype obtained from haplotype frequencies
<italic toggle="yes">f</italic>.</p>
    </sec>
    <sec>
      <title>2.3 Software presentation</title>
      <p>Easy-HLA input is an HLA genotype for each gene (HLA-A, -B, -C, -DRB1 and -DQB1),
accepting various levels of HLA nomenclature [<xref rid="btz875-T1" ref-type="table">Table 1</xref>—serology resolution, generic HLA genotyping obtained by molecular
biology or codes gathering different HLA alleles (NMDP/MAC UI codes)], as well as missing
or incomplete genotypes (<xref rid="btz875-F1" ref-type="fig">Fig. 1</xref>). After
logging into a personal account, the user has to enter a genotype and select the reference
population matching his/her data among six: African-Americans, Asian/Pacific Islanders,
Europeans, Hispanics, Native-Americans or French. Alternatively, it is possible to run a
search on all combined populations, in that case the output does not provide any
frequencies, but indicates the population in which the haplotypes are the most frequent.
All data are securely collected, processed and stored. In batch mode, the user uploads a
file containing the set of genotypes (automatically deleted after the imputation). In
addition, the post-probability threshold (confidence value) should be chosen carefully as
it impacts the call rate (chance to have a result) and output accuracy (see below and
<xref rid="btz875-F2" ref-type="fig">Fig. 2</xref>). On the user interface, a field is
available to specify a frequency threshold to further restrict the list of possible
diplotypes. Indeed, genotypes with a post-probability below the selected threshold are
automatically excluded to prevent an over-representation of rare genotypes. Overall,
Easy-HLA displays the different high-resolution genotypes with their likelihood and
post-probability starting with the most probable one (<xref rid="btz875-F1" ref-type="fig">Fig. 1A</xref>). Optionally, it is possible to select only the most probable
high-resolution genotype (in batch mode). When our algorithm does not find a corresponding
pair of haplotypes in the reference dataset for a given genotype, it cannot make a
prediction and returns an information message: ‘No matching donor found with your selected
criteria’. However, in the HLA-2-Haplo module, if one reported haplotype corresponds to
half the given genotype, the algorithm infers the missing second haplotype to propose a
haplotype pair solving the genotype. </p>
      <fig position="float" id="btz875-F1">
        <label>Fig. 1.</label>
        <caption>
          <p>Easy-HLA software presentation. (<bold>A</bold>) Example of the single query mode.
The patient genotype is entered for each gene in first or second-field, serology, NMDP
codes or left empty. The user must choose the output resolution (2: second-field, 1:
first-field, 0: empty), the post-probability threshold and reference population. The
output table contains full mid to high-resolution genotypes with their respective
likelihood and post-probability. (<bold>B</bold>) Easy-HLA delivers updated
<italic toggle="yes">HLA</italic> information from low-resolution <italic toggle="yes">HLA</italic> typing. In
this example, we start with a classical <italic toggle="yes">HLA</italic> serological genotype
(A∼B∼DRB1∼DQB1). HLA-Upgrade statistically predicts high-resolution genotypes (left
panel), and can also predict an untyped locus, such as <italic toggle="yes">HLA-C</italic> (middle
panel). Finally, HLA-2-Haplo imputes the most likely haplotype pair. These predictions
are all done <italic toggle="yes">in silico</italic> and as such prevent from additional genotyping
in the laboratory</p>
        </caption>
        <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="btz875f1" position="float"/>
      </fig>
      <fig position="float" id="btz875-F2">
        <label>Fig. 2.</label>
        <caption>
          <p>Validation of the HLA-Upgrade module in the European (EUR, left) and African-American
(AFA, right) populations (post-probability threshold set at 0%). HLA-A∼B∼C∼DRB1∼DQB1
high-resolution genotypes were predicted from different gene combinations of
first-field genotypes: HLA-A∼B∼DRB1 (blue), HLA-A∼B∼C∼DRB1 (red), HLA-A∼B∼C∼DRB1∼DQB1
(dark blue). (<bold>A</bold>) Prediction accuracy per locus. (<bold>B</bold>)
Prediction accuracy according to genotype post-probability. (<bold>C</bold>) Call rate
according to genotype post-probability. (<bold>D</bold>) Prediction accuracy according
to call rate. (Color version of this figure is available at
<italic toggle="yes">Bioinformatics</italic> online.)</p>
        </caption>
        <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="btz875f2" position="float"/>
      </fig>
      <p>The HLA-Upgrade module can predict a full 5-loci HLA-A, -B, -C, -DRB1 and -DQB1
genotyping at high-resolution level by statistically resolving missing, low-resolution or
ambiguous typings such as NMDP codes. By updating HLA genotypes, HLA-Upgrade empowers the
analysis of old cohorts or cohorts with a long delay of recruitment (<xref rid="btz875-F1" ref-type="fig">Fig. 1B</xref>), for which HLA-C and HLA-DQB1 genes are often missing
(only recently added in routine genotyping).</p>
      <p>The HLA-2-Haplo module predicts the most likely haplotype pair from a given genotype
(<xref rid="btz875-F1" ref-type="fig">Fig. 1B</xref>) and provides their frequencies in
different populations. HLA-2-Haplo can be a particularly useful tool to determine if
unrelated individuals have a chance to be haplo-identical in an HSCT clinical setting and
to provide <xref rid="sup1" ref-type="supplementary-material">Supplementary
Material</xref> for research. To solve phasing ambiguity for a given HLA genotype, our
algorithm compares the potential haplotype pairs with the previously reported haplotypes
stored in our large reference database, and can impute the second haplotype if only one
haplotype from the diplotype was previously observed. Three additional functions, only
available in batch mode, are offered with this module: (i) HLA-expr delivers HLA-C
predicted expression (based on allele specific mean HLA-C expression, see (<xref rid="btz875-B5819373615" ref-type="bibr">Vince <italic toggle="yes">et al.</italic>, 2016</xref>);
(ii) HLA-AA provides HLA alleles amino acids and (iii) HLA-KIRlig indicates the KIR
(Killer-cell immunoglobulin-like receptor) binding group (C1/C2 groups, Bw4/Bw6 or KIR2DL2
ligands) for each individual HLA allele.</p>
    </sec>
  </sec>
  <sec>
    <title>3 Performance</title>
    <sec>
      <title>3.1 HLA-Upgrade validation</title>
      <p>We validated the HLA-Upgrade module using two independent cohorts of unrelated
individuals with high-resolution (second-field) HLA genotyping for HLA-A∼B∼C∼DRB1∼DQB1
loci: (i) 1579 Europeans from the Nantes blood center and (ii) 917 individuals of African
ancestry from Consortium on Asthma among African-ancestry Populations in the Americas
(<xref rid="btz875-B2" ref-type="bibr">Barnes <italic toggle="yes">et al.</italic>, 1996</xref>;
<xref rid="btz875-B21" ref-type="bibr">Mathias <italic toggle="yes">et al.</italic>, 2016</xref>). To
evaluate the database exhaustiveness on the presence of haplotypes from both cohorts in
the database, we tested HLA genotypes at high-resolution from both cohorts in HLA-Upgrade.
We found 96.5% of the European cohort genotypes and 70.1% of the African-American cohort
genotypes represented in the database. From these full high-resolution datasets, we
simulated low-resolution HLA genotypes for both cohorts by creating 12 different
situations based on four resolution levels [first-field, second-field, serology and NMDP
simulated with correspondence table (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.ebi.ac.uk/ipd/imgt/hla/" ext-link-type="uri">https://www.ebi.ac.uk/ipd/imgt/hla/</ext-link>)] and on three levels of input loci
(HLA-A∼B∼DRB1, HLA-A∼B∼C∼DRB1 and HLA-A∼B∼C∼DRB1∼DQB1). We used HLA-Upgrade to predict
full HLA-A∼B∼C∼DRB1∼DQB1 high-resolution genotypes for each of the 12 simulated datasets,
and defined accuracy as the percentage of correct predictions compared to the original HLA
typing. We defined call rate as the number of predictions compared to the total number of
expected predictions.</p>
      <p>The resolution level impacts prediction accuracy, prediction is almost twice as good for
intermediate-resolution (NMDP) and high-resolution (second-field) genotypes compared to
low-resolution genotype (serology and first-field) (<xref rid="sup1" ref-type="supplementary-material">Supplementary Fig. S1</xref>). For the
HLA-A∼B∼C∼DRB1∼DQB1 genotype, the prediction accuracy was 58.1%, 58.6%, 97.6% and 100% for
first-field, serology, NMDP and second-field resolution level, respectively.
Interestingly, split serology was as accurate as first-field HLA genotyping, meaning that
the erroneous predictions are not based on split antigens. Second, results obtained from
NMDP codes and second-field HLA typing did not differ drastically, emphasizing the typing
precision of the high-definition sequence specific oligonucleotide. Similarly, the level
of input loci impacts the prediction accuracy (<xref rid="sup1" ref-type="supplementary-material">Supplementary Fig. S1</xref> and <xref rid="btz875-F2" ref-type="fig">Fig.
2A</xref>): inputs lacking alleles from one gene (HLA-C or HLA-DQB1) resulted in a drop
of accuracy. On average, HLA-C prediction was 20 points better when HLA-C was provided in
input (<xref rid="btz875-F2" ref-type="fig">Fig. 2A</xref>). We showed similar results
from inputs lacking HLA-DQB1 in the African cohort. The prediction accuracy per locus in
the European cohort from first-field resolution HLA-A∼B∼C∼DRB1∼DQB1 genotype inputs was
97% for HLA-A, 93% for HLA-B, 96% for HLA-C, 86% for HLA-DRB1 and 93% for HLA-DQB1 (<xref rid="btz875-F2" ref-type="fig">Fig. 2A</xref>, left panel). As a comparison, the
prediction accuracy per locus in the African-American cohort was 87%, 90%, 89%, 78% and
92% for HLA-A, -B, -C, -DRB1 and -DQB1, respectively (<xref rid="btz875-F2" ref-type="fig">Fig. 2A</xref>, right panel). The prediction accuracy by locus for the European cohort
was on average 10 points higher than for the African-derived cohort, probably because of
the smaller sample size and larger HLA haplotype diversity in African-ancestry
populations.</p>
      <p>For each input level (3, 4 or 5 genes), prediction accuracy (<xref rid="btz875-F2" ref-type="fig">Fig. 2B</xref>) and call rate (<xref rid="btz875-F2" ref-type="fig">Fig. 2C</xref>) of the full genotype change almost linearly with an increasing
post-probability threshold (confidence measure). For the 5-loci input level, accuracy
increased from 58% to 92% in Europeans and from 35% to 64% in African-Americans for a
post-probability threshold going from 0% (accepts everything) to 90% (includes genotypes
with post-probability &gt; 90%), respectively. On the contrary, call rate decreased from
100% to 20% in Europeans and from 100% to 10% in African-Americans for a threshold
increasing from 0% to 90%, respectively. Correspondingly for the 3-loci input level,
accuracy increased from 38% to 94% in Europeans and from 16% to 67% in African-Americans
and call rate decreased from 100% to 3% in Europeans and from 100% to 0% in
African-Americans for a post-probability threshold of 0% and 90%, respectively. Results
are consistent with the additional validation presented in <xref rid="sup1" ref-type="supplementary-material">Supplementary Fig. S4</xref>.</p>
      <p>The prediction accuracy increases as the call rate declines (<xref rid="btz875-F2" ref-type="fig">Fig. 2D</xref>), exemplifying a challenging risk/benefit balance that
limits error risk (increased accuracy) at the cost of a lower number of output results
(low call rate). The post-probability parameter is therefore crucial for HLA-Upgrade
prediction performances. By default, we recommend a post-probability threshold set at 10%
for exploratory research with HLA-Upgrade, advocating for more results with a compromise
on allele accuracy. At this threshold, we have a 100% call rate, but we eliminate
genotypes with very low frequencies for European- and African-ancestry populations.</p>
    </sec>
    <sec>
      <title>3.2 HLA-2-Haplo validation</title>
      <p>We validated HLA-2-Haplo module using two independent cohorts with high-resolution
HLA-A∼B∼C∼DRB1∼DQB1: (i) 273 European-ancestry (genotyping) and (ii) 116 African-ancestry
individuals [HLA imputation from single nucleotide polymorphism (SNP) genotypes] (<xref rid="btz875-B2" ref-type="bibr">Barnes <italic toggle="yes">et al.</italic>, 1996</xref>; <xref rid="btz875-B21" ref-type="bibr">Mathias <italic toggle="yes">et al.</italic>, 2016</xref>).
African-ancestry individuals were previously genome-wide SNP genotyped (<xref rid="btz875-B16" ref-type="bibr">Johnston <italic toggle="yes">et al.</italic>, 2017</xref>) and we
imputed HLA alleles for the 5-loci HLA-A, -B, -C, -DRB1 and -DQB1 with the HIBAG R package
(<xref rid="btz875-B30" ref-type="bibr">Zheng <italic toggle="yes">et al.</italic>, 2014</xref>). For
each individual, we deduced haplotype pairs from parental HLA typing (hereditary familial
study with parents/child trios). The method used is segregation analysis. Families were
selected with an ascending minimum of one first degree relative (parents/children, <xref rid="sup1" ref-type="supplementary-material">Supplementary Fig. S6</xref>).</p>
      <p>For each validation cohort, we predicted haplotypes with HLA-2-Haplo from the 5-HLA loci
in high-resolution (<xref rid="btz875-F3" ref-type="fig">Fig. 3</xref>). Similar to
HLA-Upgrade, post-probability measures the confidence of predicted haplotypes based on
frequency. Prediction accuracy ranged from 76% to 90% in Europeans and from 70% to 86% in
African-Americans with a post-probability from 0% to 90%, respectively (<xref rid="btz875-F3" ref-type="fig">Fig. 3A</xref>). For both cohorts, we observed a drop of
call rate after the post-probability threshold reached 40% and down to 45% for the 90%
post-probability threshold (<xref rid="btz875-F3" ref-type="fig">Fig. 3B</xref>). Overall,
prediction accuracy is relatively stable across call rates (<xref rid="btz875-F3" ref-type="fig">Fig. 3C</xref>). For HLA-2-Haplo, we recommend a default
post-probability threshold of 30%, where the call rate reaches a maximum whereas
ambiguities with rare genotypes are minimal: call rate is then 99% and 96%, and accuracy
is 70% and 76% for the African- and European-ancestry populations, respectively. </p>
      <fig position="float" id="btz875-F3">
        <label>Fig. 3.</label>
        <caption>
          <p>Validation of the HLA-2-Haplo module in the European (EUR, dark blue) and
African-American (AFA, red) populations. (<bold>A</bold>) Accuracy of haplotypes pairs
prediction according to the calculated post-probability. (<bold>B</bold>) Call rate of
haplotypes pairs prediction according to the calculated post-probability.
(<bold>C</bold>) Accuracy of haplotypes pairs prediction according to the call rate.
(Color version of this figure is available at <italic toggle="yes">Bioinformatics</italic>
online.)</p>
        </caption>
        <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="btz875f3" position="float"/>
      </fig>
      <p>Using the same validation cohorts, we compared performance of haplotype pair prediction
between HLA-2-Haplo and the ‘haplo.stats’ R package (<xref rid="btz875-B25" ref-type="bibr">Schaid <italic toggle="yes">et al.</italic>, 2002</xref>), a statistical tool based
on a maximum likelihood method for haplotyping when linkage phase is ambiguous in cohort
studies (‘haplo.em’ function). Unlike the usual EM tools, their algorithm considers more
than two alleles per locus, accept missing allele, and use a ‘progressive insertion’: the
algorithm progressively inserts batches of loci into haplotypes of growing lengths before
iterating over the EM steps.</p>
      <p>We tested the impact of different sampling sizes for input genotypes (10, 50, 100 or all
cohort) on the prediction accuracy (<xref rid="sup1" ref-type="supplementary-material">Supplementary Fig. S2</xref> and <xref rid="sup1" ref-type="supplementary-material">Table S1</xref>). Compared to HLA-2-Haplo predictions for Europeans (76% accuracy) and
African-Americans (70% accuracy), the ‘haplo.stats’ predictions were very dependent of
sampling size and accuracy was systematically lower than HLA-2-Haplo. ‘haplo.stats’
accurately predicted 22.6% (21.7–23.5) with 10 genotypes, 36.8% (36.4–37.1) with 100 and
up to 46.1% (46.0–46.2) with the Europeans whole cohort (<italic toggle="yes">n</italic> = 273) and
14.9% (14.1–15.7) with 10 genotypes, 40.5% (40.3–40.7) with 100 and up to 42.4%
(42.2–42.6) with the African-Americans whole cohort (<italic toggle="yes">n</italic> = 116). Our
results are therefore ‘more reproducible’, in the sense that a given genotype will always
output the same results no matter what other individual observations are in the dataset.
This methodological characteristic explains why sample size does not impact prediction
accuracy (70% for AFA and 76% for EUR) with HLA-2-Haplo.</p>
    </sec>
    <sec>
      <title>3.3 Execution</title>
      <p>To test our tools’ performance, we evaluated HLA-Upgrade runtime on under 48 conditions
with a post-probability threshold of 0% and only the first result in output (<xref rid="sup1" ref-type="supplementary-material">Supplementary Fig. S3</xref>) including:
two ancestral populations (European and African-American), four input file sizes (10 100,
1000 and 5000 genotypes), three resolutions (Split serological resolution, first-field and
second-field) and two loci combinations (A∼B∼DRB1 and A∼B∼C∼DRB1∼DQB1).</p>
      <p>HLA-Upgrade took ∼12 s to analyze files with 100-s field A∼B∼DRB1 genotypes of European
ancestry, 8.6 min in first-field and 6.6 min in split serology. We observed a linear
runtime progression with the different file sizes (<xref rid="sup1" ref-type="supplementary-material">Supplementary Fig. S3</xref>). First-field genotypes required a longer
execution time than the other two resolutions, which can be explained by a larger number
of possible haplotypes.</p>
      <p>In addition to input file size and resolution, execution runtime was also impacted by the
input level of missingness and the reference population database size. Indeed, a higher
number of haplotypes to browse translates into increased runtime: runtime for A∼B∼DRB1
genotypes was 3-fold longer than for A∼B∼C∼DRB1∼DQB1 genotypes and Europeans (304 697
haplotypes in the reference database) took on average 3-fold longer than African-Americans
(198 216 haplotypes in the reference database).</p>
    </sec>
  </sec>
  <sec>
    <title>4 Discussion</title>
    <p>Easy-HLA is a web application suite designed to facilitate large-scale immunogenetic
analyses and gain knowledge from HLA typing, regardless of the variety of nomenclature or
typing methods. In this report, we presented two tools, HLA-Upgrade and HLA-2-Haplo, based
on a large HLA haplotype reference database. Our tools integrate published external data
comprising a published set of haplotype frequencies estimated from bone marrow donor
registries (&gt;6.5 million individuals and 600 000 unique haplotypes) in order to
facilitate an accurate interpretation of the input dataset.</p>
    <p>HLA-Upgrade can successfully predict a full HLA-A, -B, -C, -DRB1 and -DQB1 high-resolution
genotyping in different populations from low-resolution and/or partially known HLA typing.
As expected, HLA-Upgrade performance positively correlates with HLA typing input resolution:
when there is more uncertainty or missingness in input, prediction will be lower. Users must
find a balance between highly confident results (high accuracy) and number of predicted
genotypes (call rate). From our validation cohorts, we recommend a default post-probability
threshold at 10%. At this threshold, from the first-field HLA-A∼B∼C∼DRB1∼DQB1 genotype, we
predicted a high-resolution genotype with an accuracy of 78.5–92.3% and 85.5–96.9% per HLA
locus and a call rate of 98.1% and 99.8% in African- and European-ancestry populations,
respectively. We also validated HLA-Upgrade using the 1000 Genomes project HLA data and
obtained consistent conclusions in Europeans, Africans, Hispanics and Asian-Pacific
Islanders (<xref rid="sup1" ref-type="supplementary-material">Supplementary Fig. S4</xref>).
We tested allele frequencies difference between imputed and non-imputed data: this shows a
good correlation with a very limited loss of diversity toward frequent alleles (<xref rid="sup1" ref-type="supplementary-material">Supplementary Fig. S7</xref>). Currently,
HLA-Upgrade outputs the post-probability (confidence measure) for the overall 5-loci
prediction. For future perspectives, we plan to implement an allele post-probability and a
locus post-probability to underline the high allelic variability and emphasize the impact of
rare alleles amongst the different genotypes. As a proof-of-concept, we carried out a
preliminary study to weight the accuracy by genotype frequencies. Indeed, we can consider
that rare alleles should not carry the same weight as common alleles in our computation as
they will skew the accuracy results. With weighting, our prediction is 43% point better for
the A∼B∼DRB1 genotype and 30% point for the A∼B∼C∼DRB1∼DQB1 genotype. Weighting the accuracy
computation with HLA genotype frequency considerably improved accuracy for HLA-Upgrade in
individuals of European ancestry (see <xref rid="sup1" ref-type="supplementary-material">Supplementary Fig. S5</xref>), so this strategy is very promising.</p>
    <p>The HLA-2-Haplo module accurately predicts haplotype pairs from HLA genotypes. From
high-resolution input and a 30% post-probability threshold, we obtained a 99% and 96% call
rate and 70% and 76% prediction accuracy for African- and European-ancestry populations,
respectively. Importantly, HLA-2-Haplo systematically outperforms ‘haplo.stats’, a
pre-existing HLA haplotyping R package, independently of sample size.</p>
    <p>Both Easy-HLA inference tools rely on a statistical algorithm based on HLA haplotype
frequencies from a large reference database (&gt;600 000 haplotypes from five different
ancestral populations). One major strength of our strategy is the size and diversity of our
reference registry including the biggest published haplotype frequency database from the
NMDP (<xref rid="btz875-B11" ref-type="bibr">Gragert <italic toggle="yes">et al.</italic>, 2013</xref>)
and the RFGM databases (<xref rid="btz875-B10" ref-type="bibr">Gourraud <italic toggle="yes">et
al.</italic>, 2015</xref>). However, these databases also convey most of Easy-HLA’s
limitations: exhaustiveness (96.5% European and 70.1% African-American cohort genotypes are
present in the database), population diversity coverage [mixed populations (REF)], typing
errors, resolution level and HLA loci coverage. For example, the current haplotype frequency
databases do not include HLA-DPB1. Our reference database samples HLA haplotypes from the
USA and from France and therefore does not represent exhaustive HLA genetic diversity.
However, we believe this bias is mostly compensated by the large size of the database, which
allows both an accurate estimate of haplotype frequencies and the presence of many rare
haplotypes, overall improving our predictions. Finally, Easy-HLA is flexible and our
algorithms are fully compatible to evolve regularly with future database releases.</p>
    <p>Here, we developed algorithms implemented in a user-friendly web application to facilitate
the analysis and reveal the full details of HLA typing. Easy-HLA tools are of great interest
both for biomedical research and clinical applications. First, HLA-Upgrade allows to update
archived HLA cohorts recorded in low/mid-resolutions and/or with missing loci (such as
HLA-C), which empowers the users to combine old and recent datasets to perform large
immunogenetic association analyses with various immune-related pathologies. HLA-Upgrade
could also be translated into clinics to assess HSCT compatibility between a patient and
potential donors with low/mid-resolution. Second, HLA-2-Haplo predicts haplotypes that are
the breeding-ground for further research investigations and for functional immunogenomic
annotations: HLA-C expression (HLA-expr), amino acid equivalence (HLA-AA) and KIR ligand
classification (HLA-KIRlig). Our tools are currently used in HSCT: first, for unrelated
donors search using HLA-Upgrade to update an old typing in a donor database, and second, for
haplo-identical transplantation using HLA-2-Haplo to predict haplotypes. Our tools have also
been used in biomedical research: using HLA-Upgrade, we have updated two large solid-organ
transplantation cohorts from low-resolution to high-resolution genotypes, hence empowering
us to now carry out allele, haplotype and immunogenetic data (HLA-2-Haplo additional
functionalities) associations with graft survival.</p>
    <p>In conclusion, Easy-HLA (freely available online at: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://hla.univ-nantes.fr" ext-link-type="uri">https://hla.univ-nantes.fr</ext-link>) facilitates
large-scale analyses and promotes the multi-faceted HLA expertise beyond allelic
associations. Our tool perfectly illustrates how computational and statistical modeling can
relay and upgrade high-value experimental data to better enlighten clinical practice and
sustain research.</p>
  </sec>
  <sec>
    <title>Funding</title>
    <p>The authors thank Labex IGO (ANR-11-LABX-0016-01) and IHU-CESTI for their support. Nicolas
Vince has received funding from the European Union’s Horizon 2020 research and innovation
program under the Marie Skłodowska-Curie grant agreement number 846520. dbGaP Study
Accession: phs001123.v1.p1.</p>
    <p><italic toggle="yes">Conflict of Interest</italic>: none declared.</p>
  </sec>
  <sec sec-type="supplementary-material">
    <title>Supplementary Material</title>
    <supplementary-material id="sup1" position="float" content-type="local-data">
      <label>btz875_Supplementary_Figure</label>
      <media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="btz875_supplementary_figure.docx">
        <caption>
          <p>Click here for additional data file.</p>
        </caption>
      </media>
    </supplementary-material>
  </sec>
</body>
<back>
  <ref-list id="ref1">
    <title>References</title>
    <ref id="btz875-B1">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ahmad</surname><given-names>T.</given-names></string-name></person-group><etal>et al</etal> (<year>2003</year>) <article-title>Haplotype-specific linkage
disequilibrium patterns define the genetic topography of the human MHC</article-title>.
<source>Hum. Mol. Genet</source>., <volume>12</volume>,
<fpage>647</fpage>–<lpage>656</lpage>.<pub-id pub-id-type="pmid">12620970</pub-id></mixed-citation>
    </ref>
    <ref id="btz875-B2">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Barnes</surname><given-names>K.C.</given-names></string-name></person-group><etal>et al</etal> (<year>1996</year>) <article-title>Linkage of asthma and total serum
IgE concentration to markers on chromosome 12q: evidence from Afro-Caribbean and
Caucasian populations</article-title>. <source>Genomics</source>, <volume>37</volume>,
<fpage>41</fpage>–<lpage>50</lpage>.<pub-id pub-id-type="pmid">8921368</pub-id></mixed-citation>
    </ref>
    <ref id="btz875-B3">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Clark</surname><given-names>A.G.</given-names></string-name></person-group> (<year>1990</year>) <article-title>Inference of haplotypes from
PCR-amplified samples of diploid populations</article-title>. <source>Mol. Biol.
Evol</source>., <volume>7</volume>,
<fpage>111</fpage>–<lpage>122</lpage>.<pub-id pub-id-type="pmid">2108305</pub-id></mixed-citation>
    </ref>
    <ref id="btz875-B4">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Copelan</surname><given-names>E.A.</given-names></string-name></person-group> (<year>2006</year>) <article-title>Hematopoietic stem-cell
transplantation</article-title>. <source>N. Engl. J. Med</source>.,
<volume>354</volume>, <fpage>1813</fpage>–<lpage>1826</lpage>.<pub-id pub-id-type="pmid">16641398</pub-id></mixed-citation>
    </ref>
    <ref id="btz875-B5">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Eberhard</surname><given-names>H.-P.</given-names></string-name></person-group><etal>et al</etal> (<year>2013</year>) <article-title>Comparative validation of computer
programs for haplotype frequency estimation from donor registry data</article-title>.
<source>Tissue Antigens</source>, <volume>82</volume>,
<fpage>93</fpage>–<lpage>105</lpage>.<pub-id pub-id-type="pmid">23849067</pub-id></mixed-citation>
    </ref>
    <ref id="btz875-B6">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Erlich</surname><given-names>H.</given-names></string-name></person-group> (<year>2012</year>) <article-title>HLA DNA typing: past, present, and
future</article-title>. <source>Tissue Antigens</source>, <volume>80</volume>,
<fpage>1</fpage>–<lpage>11</lpage>.<pub-id pub-id-type="pmid">22651253</pub-id></mixed-citation>
    </ref>
    <ref id="btz875-B7">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Excoffier</surname><given-names>L.</given-names></string-name>, <string-name><surname>Slatkin</surname><given-names>M.</given-names></string-name></person-group>
(<year>1995</year>) <article-title>Maximum-likelihood estimation of molecular haplotype
frequencies in a diploid population</article-title>. <source>Mol. Biol. Evol</source>.,
<volume>12</volume>, <fpage>921</fpage>–<lpage>927</lpage>.<pub-id pub-id-type="pmid">7476138</pub-id></mixed-citation>
    </ref>
    <ref id="btz875-B8">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Goodin</surname><given-names>D.S.</given-names></string-name></person-group><etal>et al</etal> (<year>2018</year>) <article-title>Highly conserved extended haplotypes
of the major histocompatibility complex and their relationship to multiple sclerosis
susceptibility</article-title>. <source>PLoS One</source>, <volume>13</volume><fpage>,
e0190043</fpage>.<pub-id pub-id-type="pmid">29438392</pub-id></mixed-citation>
    </ref>
    <ref id="btz875-B9">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Gourraud</surname><given-names>P.-A.</given-names></string-name></person-group><etal>et al</etal> (<year>2005</year>) <article-title>Inferred HLA haplotype information
for donors from hematopoietic stem cells donor registries</article-title>. <source>Hum.
Immunol</source>., <volume>66</volume>,
<fpage>563</fpage>–<lpage>570</lpage>.<pub-id pub-id-type="pmid">15935894</pub-id></mixed-citation>
    </ref>
    <ref id="btz875-B10">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Gourraud</surname><given-names>P.-A.</given-names></string-name></person-group><etal>et al</etal> (<year>2015</year>) <article-title>High-resolution HLA-A, HLA-B, and
HLA-DRB1 haplotype frequencies from the French Bone Marrow Donor
Registry</article-title>. <source>Hum. Immunol</source>., <volume>76</volume>,
<fpage>381</fpage>–<lpage>384</lpage>.<pub-id pub-id-type="pmid">25637665</pub-id></mixed-citation>
    </ref>
    <ref id="btz875-B11">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Gragert</surname><given-names>L.</given-names></string-name></person-group><etal>et al</etal> (<year>2013</year>) <article-title>Six-locus high resolution HLA
haplotype frequencies derived from mixed-resolution DNA typing for the entire US donor
registry</article-title>. <source>Hum. Immunol</source>., <volume>74</volume>,
<fpage>1313</fpage>–<lpage>1320</lpage>.<pub-id pub-id-type="pmid">23806270</pub-id></mixed-citation>
    </ref>
    <ref id="btz875-B12">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Held</surname><given-names>P.J.</given-names></string-name></person-group><etal>et al</etal> (<year>1994</year>) <article-title>The impact of HLA mismatches on the
survival of first cadaveric kidney transplants</article-title>. <source>N. Engl. J.
Med</source>., <volume>331</volume>,
<fpage>765</fpage>–<lpage>770</lpage>.<pub-id pub-id-type="pmid">8065404</pub-id></mixed-citation>
    </ref>
    <ref id="btz875-B13">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Horton</surname><given-names>R.</given-names></string-name></person-group><etal>et al</etal> (<year>2004</year>) <article-title>Gene map of the extended human
MHC</article-title>. <source>Nat. Rev. Genet</source>., <volume>5</volume>,
<fpage>889</fpage>–<lpage>899</lpage>.<pub-id pub-id-type="pmid">15573121</pub-id></mixed-citation>
    </ref>
    <ref id="btz875-B14">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Howell</surname><given-names>W.M.</given-names></string-name></person-group><etal>et al</etal> (<year>2010</year>) <article-title>The HLA system: immunobiology, HLA
typing, antibody screening and crossmatching techniques</article-title>. <source>J.
Clin. Pathol</source>., <volume>63</volume>,
<fpage>387</fpage>–<lpage>390</lpage>.<pub-id pub-id-type="pmid">20418230</pub-id></mixed-citation>
    </ref>
    <ref id="btz875-B15">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hurley</surname><given-names>C.K.</given-names></string-name></person-group><etal>et al</etal> (<year>2004</year>) <article-title>Hematopoietic stem cell donor
registry strategies for assigning search determinants and matching
relationships</article-title>. <source>Bone Marrow Transplant</source>,
<volume>33</volume>, <fpage>443</fpage>–<lpage>450</lpage>.<pub-id pub-id-type="pmid">14676778</pub-id></mixed-citation>
    </ref>
    <ref id="btz875-B16">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Johnston</surname><given-names>H.R.</given-names></string-name></person-group><etal>et al</etal> (<year>2017</year>) <article-title>Identifying tagging SNPs for African
specific genetic variation from the African Diaspora Genome</article-title>.
<source>Sci. Rep</source>., <volume>7</volume>, <fpage>46398</fpage>.<pub-id pub-id-type="pmid">28429804</pub-id></mixed-citation>
    </ref>
    <ref id="btz875-B17">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lee</surname><given-names>S.J.</given-names></string-name></person-group><etal>et al</etal> (<year>2007</year>) <article-title>High-resolution donor-recipient HLA
matching contributes to the success of unrelated donor marrow
transplantation</article-title>. <source>Blood</source>, <volume>110</volume>,
<fpage>4576</fpage>–<lpage>4583</lpage>.<pub-id pub-id-type="pmid">17785583</pub-id></mixed-citation>
    </ref>
    <ref id="btz875-B18">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Loiseau</surname><given-names>P.</given-names></string-name></person-group><etal>et al</etal> (<year>2007</year>) <article-title>HLA association with hematopoietic
stem cell transplantation outcome: the number of mismatches at HLA-A, -B, -C, -DRB1, or
-DQB1 is strongly associated with overall survival</article-title>. <source>Biol. Blood
Marrow Transplant</source>, <volume>13</volume>,
<fpage>965</fpage>–<lpage>974</lpage>.<pub-id pub-id-type="pmid">17640601</pub-id></mixed-citation>
    </ref>
    <ref id="btz875-B19">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>MacArthur</surname><given-names>J.</given-names></string-name></person-group><etal>et al</etal> (<year>2017</year>) <article-title>The new NHGRI-EBI catalog of
published genome-wide association studies (GWAS Catalog)</article-title>.
<source>Nucleic Acids Res</source>., <volume>45</volume>,
<fpage>D896</fpage>–<lpage>D901</lpage>.<pub-id pub-id-type="pmid">27899670</pub-id></mixed-citation>
    </ref>
    <ref id="btz875-B20">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Madbouly</surname><given-names>A.</given-names></string-name></person-group><etal>et al</etal> (<year>2014</year>) <article-title>Validation of statistical imputation
of allele-level multilocus phased genotypes from ambiguous HLA
assignments</article-title>. <source>Tissue Antigens</source>, <volume>84</volume>,
<fpage>285</fpage>–<lpage>292</lpage>.<pub-id pub-id-type="pmid">25040134</pub-id></mixed-citation>
    </ref>
    <ref id="btz875-B21">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Mathias</surname><given-names>R.A.</given-names></string-name></person-group><etal>et al</etal> (<year>2016</year>) <article-title>A continuum of admixture in the
Western Hemisphere revealed by the African Diaspora genome</article-title>. <source>Nat.
Commun</source>., <volume>7</volume>, <fpage>12522</fpage>.<pub-id pub-id-type="pmid">27725671</pub-id></mixed-citation>
    </ref>
    <ref id="btz875-B22">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Pappas</surname><given-names>D.J.</given-names></string-name></person-group><etal>et al</etal> (<year>2015</year>) <article-title>Comparison of high-resolution human
leukocyte antigen haplotype frequencies in different ethnic groups: consequences of
sampling fluctuation and haplotype frequency distribution tail
truncation</article-title>. <source>Hum. Immunol</source>., <volume>76</volume>,
<fpage>374</fpage>–<lpage>380</lpage>.<pub-id pub-id-type="pmid">25637668</pub-id></mixed-citation>
    </ref>
    <ref id="btz875-B23">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Robinson</surname><given-names>J.</given-names></string-name></person-group><etal>et al</etal> (<year>2015</year>) <article-title>The IPD and IMGT/HLA database:
allele variant databases</article-title>. <source>Nucleic Acids Res</source>.,
<volume>43</volume>, <fpage>D423</fpage>–<lpage>D431</lpage>.<pub-id pub-id-type="pmid">25414341</pub-id></mixed-citation>
    </ref>
    <ref id="btz875-B24">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Salem</surname><given-names>R.M.</given-names></string-name></person-group><etal>et al</etal> (<year>2005</year>) <article-title>A comprehensive literature review of
haplotyping software and methods for use with unrelated individuals</article-title>.
<source>Hum. Genomics</source>, <volume>2</volume>,
<fpage>39</fpage>–<lpage>66</lpage>.<pub-id pub-id-type="pmid">15814067</pub-id></mixed-citation>
    </ref>
    <ref id="btz875-B25">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Schaid</surname><given-names>D.J.</given-names></string-name></person-group><etal>et al</etal> (<year>2002</year>) <article-title>Score tests for association between
traits and haplotypes when linkage phase is ambiguous</article-title>. <source>Am. J.
Hum. Genet</source>., <volume>70</volume>,
<fpage>425</fpage>–<lpage>434</lpage>.<pub-id pub-id-type="pmid">11791212</pub-id></mixed-citation>
    </ref>
    <ref id="btz875-B26">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Stephens</surname><given-names>M.</given-names></string-name>, <string-name><surname>Donnelly</surname><given-names>P.</given-names></string-name></person-group>
(<year>2003</year>) <article-title>A comparison of Bayesian methods for haplotype
reconstruction from population genotype data</article-title>. <source>Am. J. Hum.
Genet</source>., <volume>73</volume>,
<fpage>1162</fpage>–<lpage>1169</lpage>.<pub-id pub-id-type="pmid">14574645</pub-id></mixed-citation>
    </ref>
    <ref id="btz875-B27">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Tian</surname><given-names>C.</given-names></string-name></person-group><etal>et al</etal> (<year>2017</year>) <article-title>Genome-wide association and HLA
region fine-mapping studies identify susceptibility loci for multiple common
infections</article-title>. <source>Nat. Commun</source>., <volume>8</volume>,
<fpage>599</fpage>.<pub-id pub-id-type="pmid">28928442</pub-id></mixed-citation>
    </ref>
    <ref id="btz875-B5819373615">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Vince</surname><given-names>N.</given-names></string-name></person-group><etal>et al</etal> (<year>2016</year>) <article-title>HLA-C Level is regulated by a
polymorphic Oct1 binding site in the HLA-C promoter region</article-title>. <source>Am.
J. Hum. Genet</source>., <volume>99</volume>, <fpage>1353</fpage>–<lpage>1358</lpage>.
DOI: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.cell.com/ajhg/fulltext/S0002-9297(16)30436-0" ext-link-type="uri">10.1016/j.ajhg.2016.09.023</ext-link>
<pub-id pub-id-type="pmid">27817866</pub-id></mixed-citation>
    </ref>
    <ref id="btz875-B28">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Vince</surname><given-names>N.</given-names></string-name></person-group><etal>et al</etal> (<year>2014</year>) <article-title>HLA class I and KIR genes do not
protect against HIV type 1 infection in highly exposed uninfected individuals with
hemophilia A</article-title>. <source>J. Infect. Dis</source>., <volume>210</volume>,
<fpage>1047</fpage>–<lpage>1051</lpage>.<pub-id pub-id-type="pmid">24719475</pub-id></mixed-citation>
    </ref>
    <ref id="btz875-B29">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zachary</surname><given-names>A.A.</given-names></string-name>, <string-name><surname>Leffell</surname><given-names>M.S.</given-names></string-name></person-group>
(<year>2016</year>) <article-title>HLA mismatching strategies for solid organ
transplantation—a balancing act</article-title>. <source>Front. Immunol</source>.,
<volume>7</volume>, <fpage>575</fpage>.<pub-id pub-id-type="pmid">28003816</pub-id></mixed-citation>
    </ref>
    <ref id="btz875-B30">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zheng</surname><given-names>X.</given-names></string-name></person-group><etal>et al</etal> (<year>2014</year>) <article-title>HIBAG—HLA genotype imputation with
attribute bagging</article-title>. <source>Pharmacogenomics J</source>.,
<volume>14</volume>, <fpage>192</fpage>–<lpage>200</lpage>.<pub-id pub-id-type="pmid">23712092</pub-id></mixed-citation>
    </ref>
  </ref-list>
</back>
